Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[carl_52fl]

Dutton's report is a very thorough, conservative estimate. Its price target of 0.42, a 60% discount to its peers, will be upgraded closer to the 21.2 average PE of its peers, once GTEC puts in a couple of solid quarters. This valuation at 21.1 PE is over a buck.
I believe that the old GTEC was still owed these reports by Dutton, since they had a year contract with them starting mid-2007.
I'm sure we all would want to see a bigger price target immediately, but I guess we have to climb one hill at a time.